Clinical Trial Update: A Study to Evaluate IBI112 in the Treatment of Moderate to Severe Active Ulcerative Colitis [Phase 2]

View source ↗

Summary

This clinical trial update reports a Phase 2 study of IBI112 for moderate to severe active ulcerative colitis and notes its completion status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• IBI112

Snippet

Sponsor: Innovent Biologics (Suzhou) Co. Ltd. | Conditions: Ulcerative Colitis (UC) | Phase 2 | Status: COMPLETED